Savers Value Village (SVV) General Counsel Exercises Options, Sells Shares via 10b5-1

Rhea-AI Filing Summary

Richard A. Medway, General Counsel of Savers Value Village, Inc. (SVV), exercised previously granted options and sold the resulting shares under a 10b5-1 plan. On 09/17/2025 he exercised options to acquire 3,615 shares at an exercise price of $1.41 and concurrently sold those 3,615 shares at a weighted average sale price of $12.9825 under a 10b5-1 plan adopted March 10, 2025. On 09/18/2025 he exercised an additional 1,200 options at $1.41 and sold those 1,200 shares at a weighted average price of $12.9854 under the same plan. Following the transactions, the directly held shares from these exercises were reported as 0. The Form 4 also reports total common stock underlying outstanding options of 394,508 and 393,308 shares in separate line items after the transactions, reflecting the reporting of derivative securities previously granted under the 2019 Management Incentive Plan.

Positive

• Sales executed under a 10b5-1 plan, indicating pre-arranged trading and reduced risk of opportunistic insider timing
• Exercise prices were disclosed ($1.41) and weighted-average sale prices were provided (~$12.98–$13.00), showing transparent pricing information
• Vesting details for the 2019 Management Incentive Plan are explained, including time-based and performance-based components

Negative

• Shares acquired via exercise were immediately sold, resulting in 0 additional directly held shares from these transactions
• Large number of outstanding option-related shares reported (394,508 and 393,308), representing potential future dilution

Insights

Financial Analyst

TL;DR: The reporting person exercised vested options at a low exercise price and immediately sold the shares via a pre-established 10b5-1 plan.

The Form 4 discloses option exercises on 09/17/2025 and 09/18/2025 for 3,615 and 1,200 shares respectively at $1.41 per share, with same-day sales under a 10b5-1 plan at weighted average prices near $12.99. These are routine executive liquidity transactions enabled by previously granted options that were fully vested. The filings show substantial remaining option-related potential common shares reported as 394,508 and 393,308 on the derivative schedule, which represent outstanding option exposures under the 2019 Management Incentive Plan. For investors, this is a disclosure of insider monetization activity and remaining option overhang; no earnings or operational metrics are provided in this filing.

Corporate Governance Expert

TL;DR: Transactions follow governance best practices by using a pre-established 10b5-1 plan and disclosing vesting details of options.

The reporting person indicates the sales were executed pursuant to a 10b5-1 plan adopted March 10, 2025, and provides weighted-average sale prices and an undertaking to disclose per-price execution details on request. The filing also explains vesting structure for time-based and performance-based options from the 2019 plan and notes full vesting for the June 12, 2019 grant. The clarity around the plan and vesting mechanics supports compliance and transparency in insider transactions. No material governance concerns are stated in the document itself.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Medway Richard A.

(Last) (First) (Middle)

C/O SAVERS VALUE VILLAGE, INC.

11400 SE 6TH, SUITE 125

(Street)

BELLEVUE WA 98004

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Savers Value Village, Inc. [ SVV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	General Counsel

3. Date of Earliest Transaction (Month/Day/Year)
09/17/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/17/2025		M		3,615	A	$1.41	3,615	D
Common Stock	09/17/2025		S(1)		3,615	D	$12.9825(2)	0	D
Common Stock	09/18/2025		M		1,200	A	$1.41	1,200	D
Common Stock	09/18/2025		S(1)		1,200	D	$12.9854(3)	0	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option (Right to Purchase)(4)	$1.41	09/17/2025		M			3,615	(5)	06/12/2029	Common Stock	3,615	$1.41	394,508(6)	D
Option (Right to Purchase)(4)	$1.41	09/18/2025	09/18/2025	M			1,200	(5)	06/12/2029	Common Stock	1,200	$1.41	393,308(7)	D

Explanation of Responses:

1. The sale was made pursuant to a 10b5-1 Plan adopted by the reporting person on March 10, 2025.

2. This price represents the weighted average price per share of common stock of Savers Value Village, Inc. These Shares were executed at a range of prices from $12.98 to $12.99. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

3. This price represents the weighted average price per share of common stock of Savers Value Village, Inc. These Shares were executed at a range of prices from $12.98 to $13.00. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

4. Options previously granted under the Registrant's 2019 Management Incentive Plan. Each option represents the right to receive upon exercise one share of the Registrant's common stock subject to the applicable vesting and settlement conditions.

5. The June 12, 2019 stock option grant vested in substantially equal annual installments over five years starting March 28, 2020, and was fully vested on March 28, 2024.

6. Approximately 19% represents time-based options which vested in substantially equal annual installments over five years starting March 28, 2020, and approximately 81% represents performance-based options, of which 25% vested upon the initial public offering and the remainder will be eligible for vesting upon satisfaction of certain performance criteria including stock price performance.

7. Approximately 18% represents time-based options which vested in substantially equal annual installments over five years starting March 28, 2020, and approximately 82% represents performance-based options, of which 25% vested upon the initial public offering and the remainder will be eligible for vesting upon satisfaction of certain performance criteria including stock price performance.

Remarks:

	/s/ Richard Medway	09/19/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did Richard A. Medway report on Form 4 for SVV?

The Form 4 reports option exercises on 09/17/2025 for 3,615 shares and on 09/18/2025 for 1,200 shares at an exercise price of $1.41, with same-day sales under a 10b5-1 plan.

Were the sold shares part of a pre-arranged trading plan for SVV insider Richard Medway?

Yes. The sales were executed pursuant to a 10b5-1 plan adopted on March 10, 2025 as disclosed in the Form 4.

What prices were reported for the sales in the Form 4?

The reporting person disclosed weighted-average sale prices of $12.9825 (09/17/2025) and $12.9854 (09/18/2025); execution ranges were $12.98–$12.99 and $12.98–$13.00 respectively.

How many option-related common shares remain reported after these transactions?

The derivative schedule reports common stock underlying options of 394,508 and 393,308 in the respective line items following the reported transactions.

Were the options that were exercised vested?

Yes. The Form 4 states the June 12, 2019 stock option grant vested in equal annual installments and was fully vested on March 28, 2024.